Gene Ontology Analysis of Colorectal Cancer Biomarkers Probed with Affymetrix and Illumina Microarrays

Colorectal cancer is the fourth most common cause of death worldwide. Recently, many microarray experiments have been done to investigate the expression of the genes in the colorectal tissues and thus, to find the answers for its occurrence. Previously, we used experiments obtained from both Illumina and Affymetrix microarray platforms to analyze the gene expression in healthy and carcinogenic tissues. As a result we got specific sets of biomarkers that we used to build an accurate Bayesian diagnostic system. The high degree of classifier’s sensitivity and specificity intrigued us to proceed with the research of the significant genes we discovered, the biomarkers. Therefore, in this paper we aim towards biomarkers identification and the functional groups they are associated with, i.e., we performed gene ontology analysis. Investigating the genes that control the colorectal carcinogenic tissue development is of central importance to the verification of the biomarkers’ revealing method’s validity. Moreover, we showed the importance of their participation in the prior distributions modeling, which is the key part for achieving an accurate Bayesian classification, regardless their strict disease and disorder association.

[1]  Thomas Downey,et al.  A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics , 2010, Clinical & Experimental Metastasis.

[2]  Michal A. Kurowski,et al.  Transcriptome Profile of Human Colorectal Adenomas , 2007, Molecular Cancer Research.

[3]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[4]  K. Kling,et al.  B-cell leukemia protein-2 and peptide YY chemotherapy resistance in colon cancer. , 1999, American journal of surgery.

[5]  Qi Zheng,et al.  GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis , 2008, Nucleic Acids Res..

[6]  H. Hakonarson,et al.  Analysing biological pathways in genome-wide association studies , 2010, Nature Reviews Genetics.

[7]  E. Roeb,et al.  Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas , 2004, International Journal of Colorectal Disease.

[8]  S. Namkoong,et al.  Targeted cellular process profiling approach for uterine leiomyoma using cDNA microarray, proteomics and gene ontology analysis , 2003, International journal of experimental pathology.

[9]  Monika Simjanoska,et al.  Bayesian posterior probability classification of colorectal cancer probed with Affymetrix microarray technology , 2013, 2013 36th International Convention on Information and Communication Technology, Electronics and Microelectronics (MIPRO).

[10]  Ana Madevska Bogdanova,et al.  Recognition of Colorectal Carcinogenic Tissue with Gene Expression Analysis Using Bayesian Probability , 2012, ICT Innovations.

[11]  Yadong Wang,et al.  Constructing disease-specific gene networks using pair-wise relevance metric: Application to colon cancer identifies interleukin 8, desmin and enolase 1 as the central elements , 2008, BMC Systems Biology.

[12]  K. Hemminki,et al.  Systematic enrichment analysis of gene expression profiling studies identifies consensus pathways implicated in colorectal cancer development , 2011, Journal of carcinogenesis.

[13]  Timothy J. Yeatman,et al.  DNA Copy-Number Alterations Underlie Gene Expression Differences between Microsatellite Stable and Unstable Colorectal Cancers , 2008, Clinical Cancer Research.

[14]  M. Papotti,et al.  Chromogranin gene expressions in colorectal adenocarcinomas. , 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[15]  P. Laurent-Puig,et al.  Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[16]  Li Yang,et al.  Gene Expression Analysis of Peripheral Blood Cells Reveals Toll-Like Receptor Pathway Deregulation in Colorectal Cancer , 2013, PloS one.

[17]  M. Camici Guanylin peptides and colorectal cancer (CRC). , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[19]  Steven J. M. Jones,et al.  Meta-analysis of Colorectal Cancer Gene Expression Profiling Studies Identifies Consistently Reported Candidate Biomarkers , 2008, Cancer Epidemiology Biomarkers & Prevention.

[20]  J. Coxhead,et al.  Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Peilin Jia,et al.  Common variants conferring risk of schizophrenia: A pathway analysis of GWAS data , 2010, Schizophrenia Research.

[22]  Lu Xie,et al.  DigOut: viewing differential expression genes as outliers. , 2010, Journal of bioinformatics and computational biology.

[23]  K. Hemminki,et al.  Consensus Pathways Implicated in Prognosis of Colorectal Cancer Identified Through Systematic Enrichment Analysis of Gene Expression Profiling Studies , 2011, PloS one.

[24]  M. Cohen,et al.  Guanylin mRNA expression in human intestine and colorectal adenocarcinoma. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[25]  P. Laird,et al.  Genome-scale analysis of aberrant DNA methylation in colorectal cancer. , 2012, Genome research.

[26]  V. Holla,et al.  Regulation of Prostaglandin Transporters in Colorectal Neoplasia , 2008, Cancer Prevention Research.

[27]  K. Jain,et al.  Applications of biochips: from diagnostics to personalized medicine. , 2004, Current opinion in drug discovery & development.

[28]  K. Kinzler,et al.  Lessons from Hereditary Review Colorectal Cancer , 1996 .

[29]  S. Waldman,et al.  GCC signaling in colorectal cancer: Is colorectal cancer a paracrine deficiency syndrome? , 2009, Drug news & perspectives.

[30]  G. Pruneri,et al.  The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas , 2004, Virchows Archiv.

[31]  Manuel A. R. Ferreira,et al.  Gene ontology analysis of GWA study data sets provides insights into the biology of bipolar disorder. , 2009, American journal of human genetics.

[32]  Y. Atomi,et al.  Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas , 2001, British Journal of Cancer.

[33]  K. Mimori,et al.  Overexpression of matrix metalloproteinase‐7 mRNA in human colon carcinomas , 1995, Cancer.

[34]  E. Manos,et al.  The Tumor Suppressor Adenomatous Polyposis Coli and Caudal Related Homeodomain Protein Regulate Expression of Retinol Dehydrogenase L* , 2004, Journal of Biological Chemistry.

[35]  Gene Ontology Consortium The Gene Ontology (GO) database and informatics resource , 2003 .

[36]  Shin Sasaki,et al.  Distal colorectal cancers with microsatellite instability (MSI) display distinct gene expression profiles that are different from proximal MSI cancers. , 2006, Cancer research.

[37]  Ramnik J. Xavier,et al.  Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. , 2010, Blood.

[38]  M. Tatsuta,et al.  Glycine‐extended gastrin induces matrix metalloproteinase‐1‐ and ‐3‐mediated invasion of human colon cancer cells through type I collagen gel and Matrigel , 2004, International journal of cancer.

[39]  Yusuke Nakamura,et al.  Identification of a Novel Tumor-Associated Antigen, Cadherin 3/P-Cadherin, as a Possible Target for Immunotherapy of Pancreatic, Gastric, and Colorectal Cancers , 2008, Clinical Cancer Research.

[40]  Andrew J. Bulpitt,et al.  From gene expression to gene regulatory networks in Arabidopsis thaliana , 2009, BMC Systems Biology.

[41]  Zhijin Wu,et al.  Subset Quantile Normalization Using Negative Control Features , 2010, J. Comput. Biol..